iShares Genomics Immunology and Healthcare ETF Rating $22.97 +0.43 (+1.91%) Closing price 08/22/2025 04:10 PM EasternExtended Trading$22.99 +0.02 (+0.09%) As of 08/22/2025 06:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Genomics Immunology and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IDNA Aggregate RatingModerate Buy 2.68Holdings in IDNA have an aggregate rating of Moderate Buy based on 239 analyst ratings issued in the past year covering 17 companies (56.2% of the portfolio).IDNA Aggregate Price Target$22.97High Prediction$22.97Average Prediction$22.97Low Prediction$22.97Holdings in IDNA have an aggregate price target of $22.97 and a range of $22.97 to $22.97 covering 17 companies (56.2% of the portfolio).IDNA Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy6 Buy rating(s)Moderate Buy6 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Genomics Immunology and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 IDNA Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.58%REGNRegeneron Pharmaceuticals$589.48-1.5%4.8478 of 5 stars2.81$829.65 40.7%26News CoveragePositive NewsDividend Announcement4.51%INCYIncyte$85.04-1.7%4.7256 of 5 stars2.33$81.60 -4.0%18Trending NewsAnalyst Forecast4.46%MRNAModerna$27.12+3.4%4.6467 of 5 stars2.04$42.88 58.1%24News CoverageAnalyst Forecast4.40%TWSTTwist Bioscience$28.59+8.0%4.1428 of 5 stars2.73$49.40 72.8%11Positive News4.34%ACLXArcellx$71.28-0.7%2.1228 of 5 stars3.13$114.31 60.4%15News CoveragePositive News4.10%BNTXBioNTech$110.88+0.1%1.7685 of 5 stars2.76$135.80 22.5%174.10%MRKMerck & Co., Inc.$87.18+1.3%4.9865 of 5 stars2.35$107.44 23.2%20News CoveragePositive News3.76%RVMDRevolution Medicines$37.01+1.5%4.4023 of 5 stars3.00$69.92 88.9%13News CoveragePositive NewsAnalyst Revision3.49%EXELExelixis$38.63-0.2%4.9272 of 5 stars2.55$44.06 14.0%22Trending NewsAnalyst Revision3.05%BCRXBioCryst Pharmaceuticals$8.56+2.1%4.1944 of 5 stars2.90$16.70 95.1%10Positive News2.83%CELCCelcuity$52.42+4.0%1.1174 of 5 stars3.00$50.60 -3.5%5Short Interest ↑2.78%JANXJanux Therapeutics$24.30+1.3%2.3397 of 5 stars3.08$86.90 257.6%13News Coverage2.34%ABCLAbCellera Biologics$4.39+2.1%2.0936 of 5 stars3.00$8.00 82.2%6Gap Up2.30%NVAXNovavax$7.84+2.8%4.6153 of 5 stars2.13$15.57 98.6%8News CoverageAnalyst Forecast1.89%IMNMImmunome$10.30+3.5%1.7629 of 5 stars3.00$22.50 118.4%8News CoverageAnalyst ForecastGap Up1.63%IOVAIovance Biotherapeutics$2.69+5.9%4.6148 of 5 stars2.36$11.90 342.4%14News CoverageAnalyst ForecastShort Interest ↓1.62%GERNGeron$1.46+2.1%2.9695 of 5 stars2.56$4.19 186.8%9News CoverageGap Up This page (NYSEARCA:IDNA) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersIs This Stock the 'Next Nvidia'?'AI Bottleneck' Now Threatens Entire Magnificent 7 A new critical failure has appeared in the AI market, an...Altimetry | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Genomics Immunology and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Genomics Immunology and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access